HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | PE-22-28 |
|---|---|
| CAS number | 1801959-12-5 |
| Class | Neuro & other |
| Molecular formula | C35H55N11O9 |
| Molecular weight | 773.9 g/mol |
| Sequence | Gly-Val-Ser-Trp-Gly-Leu-Arg (GVSWGLR) |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 10mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; stable long-term when sealed. After reconstitution, keep at 2-8°C and use within a short period. Avoid repeated freeze-thaw cycles. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
PE-22-28 is a synthetic spadin-derived heptapeptide (sequence GVSWGLR) that selectively inhibits the TREK-1 potassium channel, studied in preclinical neurogenesis and mood-related research models.
Documentation
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the PE-22-28 reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
PE-22-28 is a synthetic heptapeptide (sequence GVSWGLR) corresponding to residues 22-28 of spadin, a sortilin-derived peptide, and is sometimes called mini-spadin. In preclinical research it is characterized as a selective TREK-1 potassium-channel inhibitor. All material is supplied strictly for laboratory and research use.
Every lot ships with a Certificate of Analysis including RP-HPLC purity (typically >=98%) and mass-spectrometry identity confirmation matching the C35H55N11O9 / ~773.9 g/mol profile. Additional data such as residual-solvent, water-content, or endotoxin testing can be provided on request for OEM programs.
The standard catalog format is 10 mg lyophilized vials with a minimum order of 50 vials. Custom fill weights and bulk quantities are quoted on RFQ for private-label and repeat buyers.
Yes. We support OEM and private-label programs including custom vial fill, labeling, and packaging. Analogs and sequence modifications built on the GVSWGLR core can be scoped on RFQ, subject to feasibility review.
Lyophilized material ships with documentation identifying it as a research-use-only chemical, not for human or veterinary use. Cold-chain or ambient shipping is selected by destination and transit time, and export paperwork is prepared per the buyer's jurisdiction.
Related compounds